Caprock Group’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,598
| Closed | -$212K | – | 998 |
|
|
2024
Q3 | $212K | Sell |
10,598
-3,505
| -25% | -$70.1K | 0.01% | 828 |
|
|
2024
Q2 | $158K | Buy |
14,103
+423
| +3% | +$4.73K | 0.01% | 813 |
|
|
2024
Q1 | $90.3K | Buy |
13,680
+1,452
| +12% | +$9.58K | 0.01% | 701 |
|
|
2023
Q4 | $55.3K | Sell |
12,228
-89
| -0.7% | -$402 | ﹤0.01% | 685 |
|
|
2023
Q3 | $44.1K | Buy |
12,317
+2,056
| +20% | +$7.36K | ﹤0.01% | 651 |
|
|
2023
Q2 | $37.9K | Buy |
+10,261
| New | +$37.9K | ﹤0.01% | 651 |
|